Panaxadiol inhibits programmed cell death-ligand 1 expression and tumour proliferation via hypoxia-inducible factor (HIF)-1α and STAT3 in human colon cancer cells
Authors:
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 155, 104727
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China
- National Natural Science Foundation of China (81660608)
- National Natural Science Foundation of China (81760657)
- Department of Science and Technology of Jilin Province (20180520057JH)
- Department of Science and Technology of Jilin Province (JJKH20191152KJ)
- Yanbian University
This publication has 40 references indexed in Scilit:
- Therapeutic Targeting of the JAK/STAT PathwayBasic & Clinical Pharmacology & Toxicology, 2013
- Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunityAutoimmunity Reviews, 2013
- Up-Regulation of PD-L1, IDO, and T regs in the Melanoma Tumor Microenvironment Is Driven by CD8 + T CellsScience Translational Medicine, 2013
- Colorectal cancer in inflammatory bowel diseases: A population-based study (1976–2008)Inflammatory Bowel Diseases, 2012
- Identification of a Novel Small Molecule HIF-1α Translation InhibitorClinical Cancer Research, 2009
- PD-1 and PD-1 ligands: from discovery to clinical applicationInternational Immunology, 2007
- Herbal remedy magnolol suppresses IL‐6‐induced STAT3 activation and gene expression in endothelial cellsBritish Journal of Pharmacology, 2006
- Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancerNature Medicine, 2005
- Tumor Hypoxia and Malignant Progression2004
- DEGRADATION OF GINSENOSIDES IN HUMANS AFTER ORAL ADMINISTRATIONDrug Metabolism and Disposition, 2003